Mofenson et al. (2005; 40[Suppl 1]:S1-84)

In an article published in the 1 February 2005 supplement of the journal (Mofenson LM, Oleske J, Serchuck L, Van Dyke R, Wilfert C. Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America. Clin Infect Dis 2005; 40(Suppl 1):S1–84), an error appeared in appendix A. In the column labelled Preferred therapies and duration, the entry for Pneumocystis jiroveci pneumonia should read “Trimethoprim-sulfamethoxazole (TMP/SMX) 15–20 mg/kg body weight TMP plus 75–100 mg/kg body weight SMX administered intravenously or by mouth in three to four divided doses daily” (not “Trimethoprim-sulfamethoxazole (TMP/SMX) 15–20 mg/kg body weight TMP plus 75–100 mg/kg body weight SMX administered intravenously or by mouth three to four times daily”). The authors regret this error.